tm
Seeing Is Believing
tm
Seeing Is Believing
Millendo Therapeutics's activity chart (see below) currently has 14 price targets and 11 ratings on display.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 122.78 days.
Most recent stock forecast was given by from LADENBURG on 06-Jan-2021. First documented stock forecast 13-Dec-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Apr-2020
$5
5 years 9 months 18 days ago
(06-Jan-2021)
2/2 (100%)
$-21.85 (-81.38%)
592
Buy Since 13-Dec-2018
$30
$26.71 (811.85%)
$360
5 years 9 months 19 days ago
(06-Jan-2021)
1/2 (50%)
$5.55 (22.70%)
20
Buy Since 11-Mar-2020
$25
6 years 6 months 18 days ago
(06-Apr-2020)
1/1 (100%)
$-73.7 (-74.67%)
26
Buy Since 07-Feb-2020
$20
$16.71 (507.90%)
$23
6 years 7 months ago
(24-Mar-2020)
2/2 (100%)
$-76.15 (-79.20%)
215
Buy Since 16-Jul-2019
$25
$21.71 (659.88%)
7 years 2 months 11 days ago
(13-Aug-2019)
2/2 (100%)
$-81.5 (-76.53%)
252
What is MLND (Millendo Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on MLND (Millendo Therapeutics)?
Which analyst has the current lower performing score on MLND (Millendo Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MLND (Millendo Therapeutics)?
Which analyst is the currently most bullish on MLND (Millendo Therapeutics)?
Which analyst is the currently most reserved on MLND (Millendo Therapeutics)?
